Man With Hemophilia A Treated for COVID-19 While on Hemlibra
A 70-year-old man with severe hemophilia A was treated for COVID-19 while…
Articles by Aisha I Abdullah PhD
Criteria for Gene Therapy Trials Can Exclude Many With Severe Hemophilia
Screening for clinical trials in gene therapy can exclude the vast majority — 92% — of severe hemophilia…
Takeda Donating Hemophilia Treatments for 5 Years to WFH Aid Program
The World Federation of Hemophilia (WFH) announced that Takeda…
Jivi Safely Prevents Bleeds in Young Boys With Severe Hemophilia A, Trial Finds
Jivi was safe and effective at preventing and treating bleeds for more than five years…
Enzyre, Takeda Expand Partnership to Develop At-home Monitoring Test
Enzyre is partnering with Takeda with a goal of developing at-home assays to help people with monitoring congenital…
Nasal Desmopressin Recall Affects Availability Through 2023
An internal investigation conducted by Ferring Pharmaceuticals into its recently recalled desmopressin nasal spray formulations found…
DASH Diet Found to Yield Health Benefits in Adolescents With Hemophilia
The Dietary Approach to Stop Hypertension (DASH) diet yields beneficial health effects, reducing…
Telehealth Favored by Hemophilia Patients at Dublin Center, Survey Finds
The widespread adoption of telehealth during the COVID-19 pandemic has improved access to…
Steroid Combo Raises Infection Risk and Remission Chances in AHA, Study Finds
Using prednisone in combination therapies increases an infection risk but also better raises the likelihood of patients…
Mononine Soon Will No Longer Be Available to Treat Hemophilia B
Mononine, a long-standing treatment to prevent and control bleeding in hemophilia B, will be discontinued due to declining demand…